Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review

INTRODUCTION: Somatostatin analogs (SSAs) are used to treat neuroendocrine tumors (NETs) and acromegaly. Two first-generation SSAs, octreotide long-acting release (OCT LAR) and lanreotide autogel/depot (LAN), are available. A systematic literature review (SLR) was conducted to investigate which char...

Descripción completa

Detalles Bibliográficos
Autores principales: Cella, David, Evans, Jennifer, Feuilly, Marion, Neggers, Sebastian, Van Genechten, Dirk, Herman, Jackie, Khan, Mohid S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799425/
https://www.ncbi.nlm.nih.gov/pubmed/33432541
http://dx.doi.org/10.1007/s12325-020-01600-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799425/
https://www.ncbi.nlm.nih.gov/pubmed/33432541
http://dx.doi.org/10.1007/s12325-020-01600-x

Ejemplares similares